{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:36:50Z","timestamp":1787971010069,"version":"build-2784847793"},"reference-count":96,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32AI055433"],"award-info":[{"award-number":["T32AI055433"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Cryptococcal meningitis persists as a significant source of morbidity and mortality in persons with HIV\/AIDS, particularly in sub-Saharan Africa. Despite increasing access to antiretrovirals, persons presenting with advanced HIV disease remains common, and Cryptococcus remains the most frequent etiology of adult meningitis. We performed a literature review and herein present the most up-to-date information on the diagnosis and management of cryptococcosis. Recent advances have dramatically improved the accessibility of timely and affordable diagnostics. The optimal initial antifungal management has been newly updated after the completion of a landmark clinical trial. Beyond antifungals, the control of intracranial pressure and mitigation of toxicities remain hallmarks of effective treatment. Cryptococcal meningitis continues to present challenging complications and continued research is needed.<\/jats:p>","DOI":"10.3390\/jof5030065","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T03:14:41Z","timestamp":1563506081000},"page":"65","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Diagnosis and Management of Central Nervous System Cryptococcal Infections in HIV-Infected Adults"],"prefix":"10.3390","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0000-8876","authenticated-orcid":false,"given":"Caleb","family":"Skipper","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Abassi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4715-0060","authenticated-orcid":false,"given":"David R","family":"Boulware","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,7,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/mmy.38.5.379.383","article-title":"Possible primary ecological niche of Cryptococcus neoformans","volume":"38","author":"Lazera","year":"2000","journal-title":"Med. Mycol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: An updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/infdis\/jiy602","article-title":"HIV-associated cryptococcal meningitis occurring at relatively higher CD4 counts","volume":"219","author":"Tugume","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/QAD.0b013e32832be0fc","article-title":"High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out","volume":"23","author":"Jarvis","year":"2009","journal-title":"AIDS"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/587667","article-title":"Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy","volume":"46","author":"Kambugu","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Boulware, D.R., Meya, D.B., Bergemann, T.L., Wiesner, D.L., Rhein, J., Musubire, A., Lee, S.J., Kambugu, A., Janoff, E.N., and Bohjanen, P.R. (2010). Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: A prospective cohort study. PLoS Med., 7.","DOI":"10.1371\/journal.pmed.1000384"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis","volume":"370","author":"Boulware","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Montezuma-Rusca, J.M., Powers, J.H., Follmann, D., Wang, J., Sullivan, B., and Williamson, P.R. (2016). Early Fungicidal Activity as a Candidate Surrogate Endpoint for All-Cause Mortality in Cryptococcal Meningitis: A Systematic Review of the Evidence. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0159727"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/0974-2727.59702","article-title":"Diagnostic value of latex agglutination in cryptococcal meningitis","volume":"1","author":"Dominic","year":"2009","journal-title":"J. Lab. Physicians"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3201\/eid2001.130906","article-title":"Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast","volume":"20","author":"Boulware","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1097\/QAI.0b013e31828e1e56","article-title":"Cost-effective diagnostic checklists for meningitis in resource-limited settings","volume":"63","author":"Durski","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/157016207780636551","article-title":"Impact of antiretroviral therapy on the relapse of cryptococcosis and survival of HIV-infected patients with cryptococcal infection","volume":"5","author":"Jongwutiwes","year":"2007","journal-title":"Curr. HIV Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kwizera, R., Nguna, J., Kiragga, A., Nakavuma, J., Rajasingham, R., Boulware, D.R., and Meya, D.B. (2014). Performance of cryptococcal antigen lateral flow assay using saliva in Ugandans with CD4 < 100. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0103156"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/cid\/cir379","article-title":"Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis","volume":"53","author":"Lindsley","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/QAI.0000000000001721","article-title":"Brief Report: Point of Care Cryptococcal Antigen Screening: Pipetting Finger-Prick Blood Improves Performance of Immunomycologics Lateral Flow Assay","volume":"78","author":"Wake","year":"2018","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/cid\/civ263","article-title":"Evaluation of Fingerstick Cryptococcal Antigen Lateral Flow Assay in HIV-Infected Persons: A Diagnostic Accuracy Study","volume":"61","author":"Williams","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Mpoza, E., Mukaremera, L., Kundura, D.A., Akampurira, A., Luggya, T., Tadeo, K.K., Pastick, K.A., Bridge, S.C., Tugume, L., and Kiggundu, R. (2018). Evaluation of a point-of-care immunoassay test kit \u2018StrongStep\u2019 for cryptococcal antigen detection. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0190652"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/cid\/cit641","article-title":"Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid","volume":"58","author":"Kabanda","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Rajasingham, R., and Boulware, D.R. (2019). Cryptococcal antigen screening and preemptive treatment\u2014How can we improve survival?. Clin. Infect. Dis.","DOI":"10.1093\/cid\/ciz488"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"ofu105","DOI":"10.1093\/ofid\/ofu105","article-title":"Detection of High Cerebrospinal Fluid Levels of (1-->3)-beta-d-Glucan in Cryptococcal Meningitis","volume":"1","author":"Rhein","year":"2014","journal-title":"Open Forum Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.diagmicrobio.2015.11.017","article-title":"Diagnostic performance of a multiplex PCR assay for meningitis in an HIV-infected population in Uganda","volume":"84","author":"Rhein","year":"2016","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.3314\/mmj.16-00002","article-title":"Identification of Disseminated Cryptococcosis Using MALDI-TOF MS and Clinical Evaluation","volume":"57","author":"Tarumoto","year":"2016","journal-title":"Med. Mycol. J."},{"key":"ref_24","unstructured":"World Health Organization (2019, January 01). Rapid Advice: Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children. Available online: www.who.int\/hiv\/pub\/cryptococcal_disease2011."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/14787210.2017.1285697","article-title":"Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings","volume":"15","author":"Lofgren","year":"2017","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"19184","DOI":"10.7448\/IAS.17.1.19184","article-title":"Meningitis in HIV-positive patients in sub-Saharan Africa: A review","volume":"17","author":"Veltman","year":"2014","journal-title":"J. Int AIDS Soc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1086\/599112","article-title":"A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_28","unstructured":"World Health Organization (2018, April 01). Guidelines for the Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children. Available online: http:\/\/www.who.int\/hiv\/pub\/guidelines\/cryptococcal-disease\/en\/."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal combinations for treatment of cryptococcal meningitis in Africa","volume":"378","author":"Molloy","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/ciw151","article-title":"Cryptococcal meningitis treatment strategies affected by the explosive cost of flucytosine in the United States: A cost-effectiveness analysis","volume":"62","author":"Merry","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.00212-12","article-title":"The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections","volume":"56","author":"Zhai","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jat\/bkt014","article-title":"Analysis of Sertraline in Postmortem Fluids and Tissues in 11 Aviation Accident Victims","volume":"37","author":"Lewis","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Rhein, J., Hullsiek, K.H., Tugume, L., Nuwagira, E., Mpoza, E., Evans, E.E., Kiggundu, R., Pastick, K.A., Ssebambulidde, K., and Akampurira, A. (2019). Adjunctive sertraline in HIV-associated cryptococcal meningitis: A randomised, placebo-controlled, double-blind phase 3 trial. Lancet Infect. Dis., 19, in press.","DOI":"10.1016\/S1473-3099(19)30127-6"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Hai, T.P., Van, A.D., Ngan, N.T.T., Nhat, L.T.H., Lan, N.P.H., Vinh Chau, N.V., Thwaites, G.E., Krysan, D., and Day, J.N. (2019). The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans. Mycoses.","DOI":"10.1111\/myc.12955"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1128\/IAI.70.6.2959-2964.2002","article-title":"Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection","volume":"70","author":"Herring","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.4049\/jimmunol.157.10.4529","article-title":"Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans","volume":"157","author":"Huffnagle","year":"1996","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1128\/IAI.66.10.4994-5000.1998","article-title":"Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans","volume":"66","author":"Decken","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1128\/IAI.00809-09","article-title":"Th2 but not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans infection","volume":"77","author":"Jain","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4049\/jimmunol.1501871","article-title":"Regulatory T Cell Induction and Retention in the Lungs Drives Suppression of Detrimental Type 2 Th Cells During Pulmonary Cryptococcal Infection","volume":"196","author":"Wiesner","year":"2016","journal-title":"J. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Wiesner, D.L., Specht, C.A., Lee, C.K., Smith, K.D., Mukaremera, L., Lee, S.T., Lee, C.G., Elias, J.A., Nielsen, J.N., and Boulware, D.R. (2015). Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004701"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/infdis\/jit099","article-title":"The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis","volume":"207","author":"Jarvis","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","article-title":"Adjunctive interferon-gamma immunotherapy for the treatment of HIV-associated cryptococcal meningitis: A randomized controlled trial","volume":"26","author":"Jarvis","year":"2012","journal-title":"AIDS"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Brouwer, M.C., McIntyre, P., Prasad, K., and van de Beek, D. (2015). Corticosteroids for acute bacterial meningitis. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD004405.pub5"},{"key":"ref_44","first-page":"Cd002244","article-title":"Corticosteroids for managing tuberculous meningitis","volume":"4","author":"Prasad","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa1509024","article-title":"Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis","volume":"374","author":"Beardsley","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11908-013-0378-5","article-title":"Central nervous system immune reconstitution inflammatory syndrome","volume":"15","author":"Bahr","year":"2013","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"Bicanic","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group","volume":"337","author":"Saag","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"ofv157","DOI":"10.1093\/ofid\/ofv157","article-title":"Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal Meningitis","volume":"2","author":"Rolfes","year":"2015","journal-title":"Open Forum Infect. Dis."},{"key":"ref_51","first-page":"293","article-title":"The efficacy of fluconazole 600 mg\/day versus itraconazole 600 mg\/day as consolidation therapy of cryptococcal meningitis in AIDS patients","volume":"86","author":"Mootsikapun","year":"2003","journal-title":"J. Med. Assoc. Thail."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM199102283240902","article-title":"A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group","volume":"324","author":"Bozzette","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199203193261203","article-title":"A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group","volume":"326","author":"Powderly","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/515110","article-title":"A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"28","author":"Saag","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/QAD.0b013e328333c005","article-title":"Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: Correlation with cerebrospinal fluid pressure","volume":"24","author":"Loyse","year":"2010","journal-title":"AIDS"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4102\/sajhivmed.v16i1.305","article-title":"Visual loss in HIV-associated cryptococcal meningitis: A case series and review of the mechanisms involved","volume":"16","author":"Moodley","year":"2015","journal-title":"S. Afr. J. HIV Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jinf.2014.10.007","article-title":"Neurological, visual, and MRI brain scan findings in 87 South African patients with HIV-associated cryptococcal meningoencephalitis","volume":"70","author":"Loyse","year":"2015","journal-title":"J. Infect."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0163-4453(92)92954-H","article-title":"Raised intracranial pressure and visual complications in AIDS patients with cryptococcal meningitis","volume":"24","author":"Johnston","year":"1992","journal-title":"J. Infect."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/313603","article-title":"Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups","volume":"30","author":"Graybill","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/QAD.0b013e32832605fe","article-title":"Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures","volume":"23","author":"Bicanic","year":"2009","journal-title":"AIDS"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: Implications for improving outcomes","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/cid\/ciu596","article-title":"The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis","volume":"59","author":"Rolfes","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_63","first-page":"19","article-title":"Feasibility study of serial lumbar puncture and acetazolamide combination in the management of elevated cerebrospinal fluid pressure in AIDS patients with cryptococcal meningitis in Uganda","volume":"35","author":"Orem","year":"2005","journal-title":"Trop. Dr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1086\/342299","article-title":"A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis","volume":"35","author":"Newton","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/01.inf.0000224316.36588.0f","article-title":"Immune reconstitution syndrome precipitated by bacille Calmette Guerin after initiation of antiretroviral therapy","volume":"25","author":"Siberry","year":"2006","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"ofu070","DOI":"10.1093\/ofid\/ofu070","article-title":"Standardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settings","volume":"1","author":"Bahr","year":"2014","journal-title":"Open Forum Infect. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/cid\/ciu094","article-title":"Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Masur","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: A comparative review of efficacy and toxicity","volume":"73","author":"Hamill","year":"2013","journal-title":"Drugs"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/jac\/33.2.203","article-title":"Administering amphotericin B\u2014A practical approach","volume":"33","author":"Khoo","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1681\/ASN.V62154","article-title":"Amphotericin B nephrotoxicity: The adverse consequences of altered membrane properties","volume":"6","author":"Sawaya","year":"1995","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood-2005-06-2564","article-title":"Amphotericin B blunts erythropoietin response to hypoxia by reinforcing FIH-mediated repression of HIF-1","volume":"107","author":"Yeo","year":"2006","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1128\/AAC.01698-15","article-title":"Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis","volume":"59","author":"Bicanic","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/hiv.12387","article-title":"Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitis","volume":"18","author":"Tugume","year":"2017","journal-title":"HIV Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"ofy105","DOI":"10.1093\/ofid\/ofy105","article-title":"Cerebral Oximetry for Detecting High-mortality Risk Patients with Cryptococcal Meningitis","volume":"5","author":"Diehl","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s10875-006-9008-4","article-title":"Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ART","volume":"26","author":"Burgess","year":"2006","journal-title":"J. Clin. Immunol."},{"key":"ref_76","first-page":"Cd012962","article-title":"Rapid initiation of antiretroviral therapy for people living with HIV","volume":"6","author":"Johnson","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1473-3099(10)70170-5","article-title":"Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: Proposed clinical case definitions","volume":"10","author":"Haddow","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/QCO.0b013e32835c21d1","article-title":"Cryptococcal immune reconstitution inflammatory syndrome","volume":"26","author":"Longley","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1177\/0956462414563630","article-title":"Cryptococcal meningoencephalitis relapse after an eight-year delay: An interplay of infection and immune reconstitution","volume":"26","author":"Katchanov","year":"2015","journal-title":"Int. J. STD AIDS"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e02063","DOI":"10.1128\/mBio.02063-17","article-title":"Immune-Mediated Damage Completes the Parabola: Cryptococcus neoformans Pathogenesis Can Reflect the Outcome of a Weak or Strong Immune Response","volume":"8","author":"Pirofski","year":"2017","journal-title":"mBio"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/655785","article-title":"Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome","volume":"202","author":"Boulware","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.diagmicrobio.2012.08.009","article-title":"Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-gamma","volume":"74","author":"Gamaletsou","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/428618","article-title":"The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy","volume":"40","author":"Shelburne","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1097\/QAD.0b013e328358daea","article-title":"Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS","volume":"26","author":"Brunel","year":"2012","journal-title":"AIDS"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1086\/649553","article-title":"Treatment of HIV-related inflammatory cerebral cryptococcoma with adalimumab","volume":"50","author":"Sitapati","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1301066","article-title":"Use of oral fluconazole during pregnancy and the risk of birth defects","volume":"369","author":"Pasternak","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1517\/14740338.2.5.475","article-title":"Antifungal drugs in pregnancy: A review","volume":"2","author":"Moudgal","year":"2003","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"ofy122","DOI":"10.1093\/ofid\/ofy122","article-title":"Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation","volume":"5","author":"Rhein","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/clinids\/21.1.28","article-title":"Clinical and host differences between infections with the two varieties of Cryptococcus neoformans","volume":"21","author":"Speed","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"ref_90","first-page":"895","article-title":"Computer tomographic findings of the brain in HIV-patients at Ramathibodi Hospital","volume":"91","author":"Hongsakul","year":"2008","journal-title":"J. Med. Assoc. Thail."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4 + cell count < or = 100 cells\/microL who start HIV therapy in resource-limited settings","volume":"51","author":"Meya","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Musubire, A.K., Boulware, D.R., Meya, D.B., and Rhein, J. (2013). Diagnosis and Management of Cryptococcal Relapse. J. AIDS Clin. Res., pii:S3-003.","DOI":"10.4172\/2155-6113.S3-003"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QAI.0000000000001669","article-title":"A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda","volume":"78","author":"Nalintya","year":"2018","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Butler, E.K., Boulware, D.R., Bohjanen, P.R., and Meya, D.B. (2012). Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051291"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: An open-label, randomised controlled trial","volume":"385","author":"Mfinanga","year":"2015","journal-title":"Lancet"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"ofv046","DOI":"10.1093\/ofid\/ofv046","article-title":"Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality","volume":"2","author":"Letang","year":"2015","journal-title":"Open Forum Infect. Dis."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/5\/3\/65\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:07:19Z","timestamp":1760188039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/5\/3\/65"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,19]]},"references-count":96,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["jof5030065"],"URL":"https:\/\/doi.org\/10.3390\/jof5030065","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,19]]}}}